Agricultural Inputs
Compare Stocks
2 / 10Stock Comparison
SMG vs LIN
Revenue, margins, valuation, and 5-year total return — side by side.
Chemicals - Specialty
SMG vs LIN — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Agricultural Inputs | Chemicals - Specialty |
| Market Cap | $3.65B | $232.56B |
| Revenue (TTM) | $3.35B | $34.66B |
| Net Income (TTM) | $90M | $7.13B |
| Gross Margin | 31.0% | 46.0% |
| Operating Margin | 11.7% | 28.8% |
| Forward P/E | 14.3x | 28.1x |
| Total Debt | $2.38B | $26.99B |
| Cash & Equiv. | $37M | $5.06B |
SMG vs LIN — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| The Scotts Miracle-… (SMG) | 100 | 44.1 | -55.9% |
| Linde plc (LIN) | 100 | 248.0 | +148.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: SMG vs LIN
Each card shows where this stock fits in a portfolio — not just who wins on paper.
SMG is the clearest fit if your priority is defensive.
- Beta 1.10, yield 4.2%, current ratio 1.27x
- Lower P/E (14.3x vs 28.1x)
- 4.2% yield, vs LIN's 1.2%
LIN carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 6 yrs, beta 0.24, yield 1.2%
- Rev growth 3.0%, EPS growth 7.1%, 3Y rev CAGR 0.6%
- 376.9% 10Y total return vs SMG's 34.9%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 3.0% revenue growth vs SMG's -3.9% | |
| Value | Lower P/E (14.3x vs 28.1x) | |
| Quality / Margins | 20.6% margin vs SMG's 2.7% | |
| Stability / Safety | Beta 0.24 vs SMG's 1.10 | |
| Dividends | 4.2% yield, vs LIN's 1.2% | |
| Momentum (1Y) | +19.3% vs LIN's +13.6% | |
| Efficiency (ROA) | 8.3% ROA vs SMG's 2.9%, ROIC 11.3% vs 13.3% |
SMG vs LIN — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
SMG vs LIN — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
LIN leads this category, winning 6 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
LIN is the larger business by revenue, generating $34.7B annually — 10.3x SMG's $3.4B. LIN is the more profitable business, keeping 20.6% of every revenue dollar as net income compared to SMG's 2.7%. On growth, LIN holds the edge at +8.2% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $3.4B | $34.7B |
| EBITDAEarnings before interest/tax | $466M | $12.1B |
| Net IncomeAfter-tax profit | $90M | $7.1B |
| Free Cash FlowCash after capex | $358M | $5.1B |
| Gross MarginGross profit ÷ Revenue | +31.0% | +46.0% |
| Operating MarginEBIT ÷ Revenue | +11.7% | +28.8% |
| Net MarginNet income ÷ Revenue | +2.7% | +20.6% |
| FCF MarginFCF ÷ Revenue | +10.7% | +14.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | -15.0% | +8.2% |
| EPS Growth (YoY)Latest quarter vs prior year | -78.5% | +13.4% |
Valuation Metrics
SMG leads this category, winning 5 of 5 comparable metrics.
Valuation Metrics
At 25.4x trailing earnings, SMG trades at a 26% valuation discount to LIN's 34.4x P/E. On an enterprise value basis, SMG's 13.8x EV/EBITDA is more attractive than LIN's 20.0x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $3.6B | $232.6B |
| Enterprise ValueMkt cap + debt − cash | $6.0B | $254.5B |
| Trailing P/EPrice ÷ TTM EPS | 25.45x | 34.40x |
| Forward P/EPrice ÷ next-FY EPS est. | 14.34x | 28.12x |
| PEG RatioP/E ÷ EPS growth rate | — | 1.36x |
| EV / EBITDAEnterprise value multiple | 13.82x | 20.04x |
| Price / SalesMarket cap ÷ Revenue | 1.07x | 6.84x |
| Price / BookPrice ÷ Book value/share | — | 5.92x |
| Price / FCFMarket cap ÷ FCF | 13.32x | 45.70x |
Profitability & Efficiency
SMG leads this category, winning 5 of 7 comparable metrics.
Profitability & Efficiency
On the Piotroski fundamental quality scale (0–9), SMG scores 7/9 vs LIN's 6/9, reflecting strong financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | — | +17.8% |
| ROA (TTM)Return on assets | +2.9% | +8.3% |
| ROICReturn on invested capital | +13.3% | +11.3% |
| ROCEReturn on capital employed | +17.4% | +13.0% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 6 |
| Debt / EquityFinancial leverage | — | 0.68x |
| Net DebtTotal debt minus cash | $2.3B | $21.9B |
| Cash & Equiv.Liquid assets | $37M | $5.1B |
| Total DebtShort + long-term debt | $2.4B | $27.0B |
| Interest CoverageEBIT ÷ Interest expense | 3.08x | 34.52x |
Total Returns (Dividends Reinvested)
LIN leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in LIN five years ago would be worth $17,813 today (with dividends reinvested), compared to $3,161 for SMG. Over the past 12 months, SMG leads with a +19.3% total return vs LIN's +13.6%. The 3-year compound annual growth rate (CAGR) favors LIN at 12.4% vs SMG's -0.8% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +6.9% | +17.3% |
| 1-Year ReturnPast 12 months | +19.3% | +13.6% |
| 3-Year ReturnCumulative with dividends | -2.5% | +41.9% |
| 5-Year ReturnCumulative with dividends | -68.4% | +78.1% |
| 10-Year ReturnCumulative with dividends | +34.9% | +376.9% |
| CAGR (3Y)Annualised 3-year return | -0.8% | +12.4% |
Risk & Volatility
LIN leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
LIN is the less volatile stock with a 0.24 beta — it tends to amplify market swings less than SMG's 1.10 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. LIN currently trades 96.3% from its 52-week high vs SMG's 86.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.10x | 0.24x |
| 52-Week HighHighest price in past year | $72.35 | $521.28 |
| 52-Week LowLowest price in past year | $52.00 | $387.78 |
| % of 52W HighCurrent price vs 52-week peak | +86.9% | +96.3% |
| RSI (14)Momentum oscillator 0–100 | 41.3 | 50.6 |
| Avg Volume (50D)Average daily shares traded | 948K | 2.3M |
Analyst Outlook
Evenly matched — SMG and LIN each lead in 1 of 2 comparable metrics.
Analyst Outlook
Wall Street rates SMG as "Buy" and LIN as "Buy". Consensus price targets imply 14.6% upside for SMG (target: $72) vs 7.5% for LIN (target: $540). For income investors, SMG offers the higher dividend yield at 4.18% vs LIN's 1.20%.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $72.00 | $539.71 |
| # AnalystsCovering analysts | 17 | 28 |
| Dividend YieldAnnual dividend ÷ price | +4.2% | +1.2% |
| Dividend StreakConsecutive years of raises | 0 | 6 |
| Dividend / ShareAnnual DPS | $2.63 | $6.00 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.5% | +2.0% |
LIN leads in 3 of 6 categories (Income & Cash Flow, Total Returns). SMG leads in 2 (Valuation Metrics, Profitability & Efficiency). 1 tied.
SMG vs LIN: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is SMG or LIN a better buy right now?
For growth investors, Linde plc (LIN) is the stronger pick with 3.
0% revenue growth year-over-year, versus -3. 9% for The Scotts Miracle-Gro Company (SMG). The Scotts Miracle-Gro Company (SMG) offers the better valuation at 25. 4x trailing P/E (14. 3x forward), making it the more compelling value choice. Analysts rate The Scotts Miracle-Gro Company (SMG) a "Buy" — based on 17 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — SMG or LIN?
On trailing P/E, The Scotts Miracle-Gro Company (SMG) is the cheapest at 25.
4x versus Linde plc at 34. 4x. On forward P/E, The Scotts Miracle-Gro Company is actually cheaper at 14. 3x.
03Which is the better long-term investment — SMG or LIN?
Over the past 5 years, Linde plc (LIN) delivered a total return of +78.
1%, compared to -68. 4% for The Scotts Miracle-Gro Company (SMG). Over 10 years, the gap is even starker: LIN returned +376. 9% versus SMG's +34. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — SMG or LIN?
By beta (market sensitivity over 5 years), Linde plc (LIN) is the lower-risk stock at 0.
24β versus The Scotts Miracle-Gro Company's 1. 10β — meaning SMG is approximately 357% more volatile than LIN relative to the S&P 500.
05Which is growing faster — SMG or LIN?
By revenue growth (latest reported year), Linde plc (LIN) is pulling ahead at 3.
0% versus -3. 9% for The Scotts Miracle-Gro Company (SMG). On earnings-per-share growth, the picture is similar: The Scotts Miracle-Gro Company grew EPS 504. 9% year-over-year, compared to 7. 1% for Linde plc. Over a 3-year CAGR, LIN leads at 0. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — SMG or LIN?
Linde plc (LIN) is the more profitable company, earning 20.
3% net margin versus 4. 3% for The Scotts Miracle-Gro Company — meaning it keeps 20. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: LIN leads at 26. 3% versus 10. 5% for SMG. At the gross margin level — before operating expenses — LIN leads at 43. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is SMG or LIN more undervalued right now?
On forward earnings alone, The Scotts Miracle-Gro Company (SMG) trades at 14.
3x forward P/E versus 28. 1x for Linde plc — 13. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for SMG: 14. 6% to $72. 00.
08Which pays a better dividend — SMG or LIN?
All stocks in this comparison pay dividends.
The Scotts Miracle-Gro Company (SMG) offers the highest yield at 4. 2%, versus 1. 2% for Linde plc (LIN).
09Is SMG or LIN better for a retirement portfolio?
For long-horizon retirement investors, Linde plc (LIN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
24), 1. 2% yield, +376. 9% 10Y return). Both have compounded well over 10 years (LIN: +376. 9%, SMG: +34. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between SMG and LIN?
Both stocks operate in the Basic Materials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: SMG is a small-cap income-oriented stock; LIN is a large-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.